Clinical Trial Update: Real-life Data of Cardiovascular Events Occuring During Degarelix Therapy for Prostate Cancer

View source ↗

Summary

Real-world data from a completed study report cardiovascular events occurring in patients treated with degarelix for advanced prostate cancer. The trial (NCT022…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Firmagon (Degarelix)

Snippet

Sponsor: Ferring Pharmaceuticals | Conditions: Advanced Hormone Sensitive Prostate Cancer | Status: COMPLETED